Invitris
PrivateLast Round
Grant
Feb 17, 2025
Est. Valuation
$1.79M
Total Funding Raised
$3.34M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Invitris is a biotechnology company that develops a cell-free protein expression platform called Phactory™ to manufacture therapeutic proteins, including bacteriophages, to combat antibiotic-resistant infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invitris Comparables
Compare Invitris with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LenioBio | 83% | |
| Tierra Biosciences | 79% | |
| Sutro Biopharma Inc | 74% | |
Invitris Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2025 | ||||
| Accelerator | Dec 19, 2024 | ||||
| Grant | May 9, 2023 | ||||
| Accelerator | Mar 10, 2023 | ||||
| Grant | Jan 27, 2022 |
Invitris Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Accelerator, Grant |
| INCATE | Grant |
| Y Combinator | Accelerator |
| another.vc | Accelerator |
| 10x Founders | Accelerator |
| Mergus Ventures | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 1403% from 61 to 917.
- May 9, 2023
$272K grant received from INCATE.
Invitris Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Invitris's valuation, stock price, and market status.